Single-Arm Phase II Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer
Latest Information Update: 05 Mar 2025
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Diagnostic use
- Acronyms PSMA SBRT-SIB
Most Recent Events
- 27 Feb 2025 Planned End Date changed from 31 Dec 2025 to 31 Dec 2027.
- 27 Feb 2025 Planned primary completion date changed from 31 Dec 2025 to 31 Dec 2027.
- 22 Mar 2024 Planned primary completion date changed from 31 Dec 2023 to 31 Dec 2025.